1017 | 1.358 | 7.156 | 3.686 | 0.0002705 | 0.002359 | -0.08122 | 1017 | CDK2 | cyclin-dependent kinase 2 | ENSG00000123374 | 116953 |
11073 | -0.9076 | 9.347 | -5.881 | 1.097e-08 | 4.777e-07 | 9.487 | 11073 | TOPBP1 | topoisomerase (DNA) II binding protein 1 | ENSG00000163781 | 607760 |
2130 | -0.3305 | 11.49 | -3.354 | 0.0008993 | 0.006292 | -1.187 | 2130 | EWSR1 | Ewing sarcoma breakpoint region 1 | ENSG00000182944 | 133450, 612219 |
4361 | -0.4277 | 9.002 | -4.341 | 1.947e-05 | 0.000268 | 2.375 | 4361 | MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | ENSG00000020922 | 600814, 604391 |
4683 | -1.473 | 9.212 | -10.58 | 2.141e-22 | 5.298e-19 | 40.04 | 4683 | NBN | nibrin | ENSG00000104320 | 251260, 602667 |
4869 | -0.3218 | 12.91 | -3.351 | 0.00091 | 0.006341 | -1.198 | 4869 | NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | ENSG00000181163 | 164040, 601626 |
5111 | -0.2477 | 11.68 | -3.358 | 0.0008885 | 0.00623 | -1.176 | 5111 | PCNA | proliferating cell nuclear antigen | ENSG00000132646 | 176740 |
545 | -1.109 | 8.796 | -6.091 | 3.466e-09 | 1.821e-07 | 10.59 | 545 | ATR | ataxia telangiectasia and Rad3 related | ENSG00000175054 | 210600, 601215 |
55120 | -1.129 | 9.14 | -6.468 | 4.09e-10 | 2.987e-08 | 12.65 | 55120 | FANCL | Fanconi anemia, complementation group L | ENSG00000115392 | 608111, 614083 |
5591 | -0.6372 | 9.881 | -5.27 | 2.63e-07 | 7.27e-06 | 6.451 | 5591 | PRKDC | protein kinase, DNA-activated, catalytic polypeptide | ENSG00000253729 | 600899 |
7323 | -0.3098 | 10.44 | -5.53 | 7.025e-08 | 2.339e-06 | 7.71 | 7323 | UBE2D3 | ubiquitin-conjugating enzyme E2D 3 | ENSG00000109332 | 602963 |
7332 | -0.4184 | 9.08 | -4.981 | 1.076e-06 | 2.374e-05 | 5.111 | 7332 | UBE2L3 | ubiquitin-conjugating enzyme E2L 3 | ENSG00000185651 | 603721 |